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Abstract
Doxorubicin disrupts spermatogenesis by causing apoptosis of
spermatogonia and primary spermatocytes. The aim of this
study was to examine the effect of this agent on adult rat
testicular lipids and their fatty acids. A single dose (7.5 mg/kg)
and a multidose regime (3 mg/kg once a week for 4 weeks)
were evaluated. Both treatments resulted in the gradual loss of
spermatogenic cells and determined a marked reduction in
testicular size and weight 9 weeks after their start. Germ cell
loss was accompanied by a decrease in phospholipids,
including glycerophospholipids and sphingomyelin. Concom-
itantly, glycerophospholipids lost selectively their major
polyunsaturated fatty acid (PUFA), 22:5n-6, and sphingomye-
lin lost its major very long-chain PUFA (VLCPUFA), 28:4n-6
and 30:5n-6. The molecular species from which the lost
polyenes originated were thus a trait of germ cells. A transient
peak of 16:0-ceramide was observed 48 h after the single dose.
In both doxorubicin regimes, sphingomyelin and ceramide
with reduced amounts of VLCPUFA after about 4 weeks and
with no VLCPUFA after 9 weeks resulted. By contrast,
triglycerides and especially cholesterol esters (CE) tended to
accumulate in the testes undergoing germ cell death, probably
in the surviving Sertoli cells, their fatty acid patterns
suggesting that initially, these lipids retained part of the
PUFA coming from, or no longer used for, the synthesis of
germ cell glycerophospholipids. As the latter decreased, CE
accumulated massively 9 weeks after starting doxorubicin
treatment, 20:4n-6 becoming their major PUFA. Part of these
CEs may derive from surviving steroidogenic cells. [Cancer Res
2007;67(14):6973–80]
Introduction
The anthracycline antibiotic doxorubicin, or Adriamycin, is the
antineoplasic drug of choice in the treatment of many solid tumors,
although one of its adverse effects is male infertility (1–3). In
response to several chemotherapeutic agents including anthracy-
clines, the number of male germ cells undergoing apoptosis
increases several fold (4). Because the cells most sensitive to
doxorubicin are the early spermatogenic cells, spermatogonia type
A and meiotically dividing primary spermatocytes (4, 5), doxoru-
bicin treatment may lead to the loss of proliferating nonmature
germ cells and eventually of mature spermatozoa. Although it is
known that anthracyclines interfere with a number of biochemical
and biological functions within eukaryotic cells, the precise
mechanisms responsible for its adverse actions on the testis have
not been completely elucidated. Knowledge of the biochemical
factors contributing to germ cell death and related epiphenomena
is important because it may help find ways of attenuating germ cell
injury without compromising the antitumor efficacy of doxorubi-
cin. For example, free radical formation and lipid peroxidation is
known to be involved in the antiproliferative/cytotoxic actions of
doxorubicin on tumor cells (6, 7). These processes also occur in the
testis of doxorubicin-treated animals, explaining the high vulner-
ability of proliferating germ cells and pointing to pretreatment with
antioxidants as a promising form of reducing doxorubicin toxicity
(8–10).
The lipids of adult mammalian testis have long been known to
contain high proportions of long-chain polyunsaturated fatty acids
(PUFA). In the rat, the most abundant PUFA of testicular
glycerophospholipids has long been known to be docosapentaenoic
acid (22:5n-6), an acyl chain that is a major acyl group of cells of
the germ line (11), although it seems to be mostly synthesized by
Sertoli cells (12). Besides the well-known PUFA of C18 to C22 carbon
atoms, the mammalian testis contains in their seminiferous tubules
a group of very long-chain PUFA (VLCPUFA) as components of
specific lipids (13, 14). The neutral lipids triacylglycerols, 1-alkyl
diacylglycerols (A-DAG) and cholesterol esters (CE) contain, in
addition to important proportions of 22:5n-6, VLCPUFA with 24 to
32 carbon atoms (15). More recently, we investigated the fatty acids
of sphingomyelin and ceramide of rat seminiferous tubules (16). In
addition to the long-chain saturated fatty acids these sphingolipids
have in most tissues and cells, they contain VLCPUFA up to C32,
28:4n-6 and 30:5n-6 prevailing in both (16). The possible changes
induced by doxorubicin on the highly unsaturated lipids of testis
have not yet been studied in detail. One of the aims of this study
was to survey these effects to find clues as to the biochemical
changes taking place in the cells that die and in those that survive,
in the testis of living animals treated with the drug.
Ceramide is known to be formed from cell membrane
sphingomyelin by specific sphingomyelinases in response to a
variety of stress-inducing factors that result in apoptotic cell death,
among which several antineoplasic drugs are counted (17–20).
Because ceramide increases in germ cells undergoing apoptosis in
seminiferous tubules in vitro (21) and because treatments with
doxorubicin induce apoptotic death of specific spermatogenic cells
in vivo (4, 5), one of the first questions was how doxorubicin
treatment would affect the ceramide and sphingomyelin of testis
and their fatty acids. However, we soon realized that doxorubicin
produced several quantitative and qualitative effects on virtually all
testicular lipids of the rat. A few of these were early changes,
whereas others could be ascribed to the long-term consequences of
the initial death of doxorubicin-sensitive germ cells. We report here
that, concomitantly with the progress of testicular involution and
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atrophy, large changes in lipid amounts as well as in their PUFA
and VLCPUFA profiles occur in rat testis, especially in the period
between 4 and 9 weeks after starting doxorubicin treatment.
Materials and Methods
Animals and doxorubicin treatments. Adult male Wistar rats 3 to
4 months old were housed under standard conditions with food and water
ad libitum. The protocols for animal experimentation were reviewed and
approved by a local institutional Animal Care and Use Committee.
Doxorubicin solution was given i.p. (7.5 mg/kg in the single-dose study
and 3 mg/kg once a week for 4 consecutive weeks in the multidose
regimen). Control rats were injected i.p. with normal saline following the
same regimes as the doxorubicin-treated groups. At scheduled points in
time, animals anesthetized with ketamine/acepromazine were weighed,
operated, and sacrificed immediately after testis removal. Testes and
epididymides were fixed in formaldehyde solution for histologic examina-
tion. The tissues were embedded in paraffin and stained with H&E.
Lipid separation and analysis. The testes were weighed, decapsulated,
and rinsed in normal saline after removal of visible blood vessels. Lipid
extracts were prepared according to the procedure of Bligh and Dyer (22)
and kept under N2. Aliquots from the extracts were taken for total lipid
phosphorus determination (23). The phospholipids were resolved into
classes on high-performance TLC plates using chloroform/methanol/acetic
acid/water (50:37.5:3.5:2, by volume; ref. 24). After TLC, lipid zones were
located by exposing the plates to iodine vapors, and the phospholipids were
quantified by phosphorus analysis of spots (23).
Neutral lipids were resolved by TLC on 500-Am-thick silica gel G plates in
two steps, using chloroform/methanol/ammonia (90:10:0.2, by volume) up
to the middle and then hexane/ether (80:20, by volume) up to the top of the
TLC plates. The bands at the origin of these plates were collected to elute
the phospholipids. Aliquots of these eluates were taken for phospholipid
and fatty acid composition analyses and for the preparative isolation of
sphingomyelin and choline glycerophospholipids (CGP). Sphingomyelin
was isolated using chloroform/methanol/acetic acid/0.15 mol/L NaCl
(50:25:8:2.5, by volume; ref. 25). The CGP were resolved by two-dimensional
TLC (23).
The lipid zones were located by exposing the TLC plates to UV light after
spraying (using N2) 2¶,7¶-dichlorofluorescein in methanol. All lipids were
eluted by transferring the silica support into glass tubes and thoroughly
mixing with chloroform/methanol/acetic acid/water (50:39:1:10, by vol-
ume), followed by centrifugation. The procedure was repeated thrice (26),
followed by partition with 1 N ammonia and drying under N2.
Figure 1. Changes in weight and total lipid phosphorus content in rat testis after a single dose (7.5 mg/kg) and after four doses, given once a week (3 mg/kg),
of doxorubicin. Right, photomicrographs of H&E sections of testis and ductus epididymidis are compared. The mentioned tissues were obtained from control
rats, from rats 24 d after a single dose of doxorubicin, and from rats 28 d and 9 wks after the four doses of doxorubicin, in that order. A-D, testis; E-H, epididymis,
respectively.
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The eluted sphingomyelin and ceramide were taken to dryness and
treated (under N2) with 0.5 N NaOH in anhydrous methanol at 50jC for
10 min to remove any potential lipid contaminant with ester-bound fatty
acids. After alkaline treatment, 1 volume each of chloroform and 0.5 N HCl
was added to the methanol solution; the organic phase was rapidly
recovered and dried, and the lipids were separated again by TLC.
Fatty acid analysis. The lipid fatty acids were analyzed by gas
chromatography after derivatization into fatty acid methyl esters. These
were prepared from lipids with 2% H2SO4 (27) in previously degassed,
HPLC-grade methanol (overnight at 45jC) in screw-capped sealed tubes,
under N2. Methyl heneicosanoate was added as an internal standard for
quantitative analysis. Before analysis, the fatty acid methyl ester samples
containing the standard were purified by TLC using hexane/ether (95:5, by
volume) on silica gel G plates that had been previously washed (with
methanol/ethyl ether, 75:25, by volume). The zones were located, the silica
support was scraped into tubes, and methyl esters were recovered by
thoroughly mixing with methanol/water/hexane (1:1:1, by volume), doing
three successive hexane extractions and centrifugations and combining the
hexane phases. The VLCPUFA or rat testicular lipids were identified as
detailed in previous work (14, 16).
A Varian 3700 gas chromatograph and a Varian Star Chromatography
Workstation (version 4.51) were used. The instrument was equipped with
two (2 mm  2 m) glass columns packed with 15% SP 2330 on Chromosorb
WAW 100/120 (Supelco, Inc.) and two flame ionization detectors, operated
in the dual-differential mode. The column oven temperature was
programmed from 150 to 230jC at a rate of 5jC/min, the final temperature
being held for 30 min to allow VLCPUFA to emerge from the column.
Injector and detector temperatures were 220 and 230jC, respectively, and
N2 (30 mL/min) was the carrier gas.
The amounts of lipids in the figures are represented by the sum of the
amounts of their fatty acids, directly, with no further corrections or
calculations. Also, for simplicity in the presentation of the fatty acid data, in
most figures, the lipid fatty acids have been grouped into saturates,
monoenes, dienes, polyunsaturates, and very long-chain polyunsaturates,
and symbolized by the letters S, M, D, P, and V, respectively.
Statistical analyses. All values shown represent mean values from at
least three rats per sampleFSD. The significance of differences was assayed
by the two-tailed Student’s t test (P < 0.05 was considered significant). All
differences with respect to controls observed 9 weeks after starting the
multidose administration of doxorubicin were statistically significant.
Results
Body and testicular weights and histologic examination. A
significant decrease in body weight gain and food consumption
was observed in animals treated with doxorubicin in comparison
with their respective control groups. On average, the increase in
body weight after 9 weeks was 50% in controls and 0% in treated
animals (data not shown). The testicular weight and size decreased
significantly in the doxorubicin-treated groups (Fig. 1). Twenty-four
days after the administration of the single dose, and 28 days after
the first of the four weekly repeated doses, the weight of the testis
decreased by 17% to 20%. Nine weeks after starting either dose
regime (data not shown) or the multidose doxorubicin regime
(Fig. 1), the testicular weight was reduced by 73% to 76%, the testes
weighing just one-fourth of those of the age-matched control rats.
The testicular weight changes were consistent with the main
histologic findings, also shown in Fig. 1. In agreement with previous
work (28), 24 days after a single dose, there was a moderate but
already noticeable loss of germ cells, the depleted cell types
included spermatogonia and spermatocytes from preleptotene to
pachytene (Fig. 1). A similar result was observed 28 days after
starting the multidose regimen, according to previous observations
(29). Nine weeks after starting the doxorubicin treatment, marked
seminiferous tubule atrophy was observed: the diameter of the
seminiferous tubules and the thickness of the germ cell layer were
markedly smaller than in the control groups. Sertoli and interstitial
cells were the main surviving cells eventually populating the
flattened tubules. In the epididymis, the changes observed
indicated severe oligospermia after 4 weeks and azoospermia after
9 weeks (Fig. 1). The infertility of rats 9 weeks after the multidose
Figure 2. Time course of the changes in the fatty acids of rat testicular sphingomyelin (SM ) and ceramide (Cer ) after a single dose (7.5 mg/kg) of doxorubicin.
The groups of fatty acids of both sphingolipids are expressed by their sums, as follows: S, saturates, M, monoenes, D, dienes, V, polyunsaturated fatty acids. Right,
changes in the amount of two VLCPUFA typical of sphingomyelin and ceramide.
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doxorubicin regimen was checked by mating the treated males
with normal females for 14 successive nights. Although copulations
occurred, no pregnancies resulted.
Taken together, the above findings suggested that after almost
1 month, the effects of doxorubicin had started, but had not reached
completion. Because doxorubicin treatment destroys stem cells
and spermatogonia but spares more of the most differentiated cells
of the germ line, such as spermatocytes and spermatids (4, 5), the
eventual long-term consequences of germ cell death on the testis
required a longer period than a few weeks to reach completion.
Because a whole spermatogenic cycle takes 63 days in the rat,
sufficient time had to be allowed for the preexisting unaffected
spermatogenic cells to have the chance to exit from the testis. This
did indeed happen 9 weeks after starting doxorubicin treatment.
Testicular lipid phosphorus. The total lipid phosphorus
content per testis decreased almost in parallel with the testicular
weight (Fig. 1). A single dose of doxorubicin resulted, 24 days
afterward, in a 24% decrease in the amount of testicular
phospholipids (Fig. 1) and 75% decrease after 9 weeks (data not
shown). Four once-a-week doses resulted in a 19% decrease in
phospholipid content after 28 days and 79% decrease in 9 weeks
(Fig. 1). The eventually massive decrease in phospholipids observed
after 9 weeks was thus associated with the annihilated population
of germ cells within the seminiferous tubules.
The content of lipids in tissues is usually expressed per unit of
weight or per unit of protein or DNA. However, considering that the
decrease in the weight and volume of the testis in the present study
was due to the loss of preexisting cells, obviously, the content of
total proteins, total lipids, and total nucleic acids per testis
diminished in parallel. Thus, we decided to show the effects of
doxorubicin on lipids and fatty acids directly on a ‘‘per-testis’’ basis.
Sphingomyelin and ceramide. In adult fertile rat testis, both
sphingomyelin and ceramide contained important proportions of
fatty acids with very long chains (VLCPUFA, C24-C32 PUFA), their
sum amounting to 13% to 17% of the total fatty acids of
sphingomyelin and 36% to 41% of those of ceramide, the rest being
the usual saturated, monoenoic, and dienoic fatty acids present in
most other tissues and cells. The fatty acids of sphingomyelin and
ceramide are represented by their sums in Figs. 2 and 3, where two
major VLCPUFA, 28:4n-6 and 30:5n-6, are also included.
Anthracyclines are expected to activate sphingomyelin hydroly-
sis and generate ceramide as a trigger of apoptosis (30). In this
study, we analyzed the relatively short-term effects of doxorubicin
on sphingomyelin and ceramide fatty acids in the animals receiving
one single dose of doxorubicin (Fig. 2) and the long-term effects in
those receiving the multidose regimen (Fig. 3). A significant
increase (35%) was observed on day 2 in the content of ceramide
(Fig. 2). Part of this ceramide could have been produced from
sphingomyelin because this lipid decreased slightly at this time
point. Interestingly, the peak of ceramide at 48 h was mainly
accounted for by its saturated fatty acids (Fig. 2) and within this
group, mostly by 16:0. The total VLCPUFA typical of ceramide
apparently did not increase at these early stages. On the contrary,
they tended to decrease more than other fatty acids in both
sphingomyelin and ceramide. Twenty-four days after the single
dose, VLCPUFA were the fatty acids that decreased the most in
both sphingolipids.
In the multidose regimen, the amounts of testicular sphingo-
myelin and ceramide decreased significantly 4 weeks after the first
dose and continued to decrease thereafter (Fig. 3). The VLCPUFA
were the protagonists of this dramatic decrease because the
sphingomyelin and ceramide that remained in the testis 9 weeks
after starting the doxorubicin treatment virtually lacked VLCPUFA.
The selective loss of VLCPUFA from both lipids thus correlated
with the selective loss of spermatogenic cells from the seminiferous
tubules.
Figure 3. Long-term effects of doxorubicin on the fatty acids of rat testicular sphingomyelin and ceramide after four doses of doxorubicin (3 mg/kg), repeated once a
week for 4 successive weeks. Other details are as in Fig. 2.
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Glycerophospholipids. Phospholipid analysis (Fig. 4) showed
that all phospholipid classes tended to decrease, although to
different extents, after doxorubicin treatments, with EGP and PS
decreasing relatively more than CGP and sphingomyelin (Fig. 4).
Total phospholipid or total glycerophospholipid fatty acid amounts
and composition were determined by taking aliquots of the total
phospholipid fraction and subjecting them to acid- or to alkali-
catalyzed methanolysis, respectively. Both forms of studying the
fatty acids gave essentially similar results, the differences being
minimal because the predominant component of the phospholipid
fraction were the glycerophospholipids (Fig. 4). In total phospho-
lipids, as in total glycerophospholipids (Fig. 5), PUFA were the
predominant fatty acids. The major constituents of the PUFA
fraction were 22:5n-6 and 20:4n-6, and the main components of the
VLCPUFA group were 24:4n-6 and 24:5n-6 (Fig. 4).
Twenty-four days after a single injection and 28 days after four
repeated injections of doxorubicin, total phospholipids or glycer-
ophospholipid fatty acids had decreased by 17% to 20%, whereas
merely one-fourth of the initial amounts remained after 9 weeks,
whether measured on the basis of total lipid phosphorus (Fig. 1) or
on the basis of fatty acids (Fig. 5). Thus, the glycerophospholipids,
quantitatively more important than any other lipid in the testis,
were the lipid constituents most decreased by doxorubicin. All
groups of phospholipid fatty acids decreased accompanying these
changes approximately at similar rates.
Although the sum of glycerophospholipid-associated PUFA had a
similar percentage in control and treated animals, major changes
were observed within this group. Thus, 22:5n-6 followed by 20:4n-6
prevailed throughout the first 24 to 28 days period after
doxorubicin treatment, but 22:5n-6 decreased much more than
20:4n-6 in the period between 4 and 9 weeks (Figs. 4 and 6). Thus,
the phospholipids present 9 weeks after doxorubicin had lost most
of their 22:5n-6 and 24:5n-6, becoming instead relatively richer in
tetraenoic fatty acids, especially 20:4n-6, and in even shorter and
less unsaturated polyenes, notably 18:2n-6.
Neutral glycerides and CEs. In adult fertile rat testis, these
neutral lipids were characterized by having important proportions
of PUFA (mostly 22:5) and VLCPUFA (C24-C32 tetraenes and
pentaenes). These polyenes are represented by their sums in Figs. 5
and 6. In agreement with previous work (15), the main VLCPUFA of
triacylglycerols (TAG) were 24:4n-6 and 24:5n-6; A-DAGs were
made up by important proportions of these C24 polyenes and also
longer pentaenes and tetraenes up to 32:5n-6; the CEs in turn had
small percentages of 24 carbon PUFA but large proportions of the
longest VLCPUFA, especially 28:5n-6, followed by 30:5n-6.
In contrast to glycerophospholipids, the amounts of triglycerides
(TAG and A-DAG) per testis were similar as in controls 24 days
after a single dose (data not shown) and 28 days after starting the
multiple injections of doxorubicin (Fig. 5). Considering that the
tissue weight and lipid P decreased, this means that the
concentration per gram of tissue or per unit of total lipid P of
these neutral lipids increased during the first 4 weeks after
doxorubicin administration. Interestingly, this was concomitant
with a change in fatty acid profiles. The PUFA and VLCPUFA
increased more than did other fatty acids in these neutral lipids,
suggesting that (a) they were no longer being used for their normal
functions, and/or (b) they were serving as a reservoir of fatty acids,
collecting those that originally were in the glycerophospholipids of
the dying spermatogenic cells. Nine weeks after the weekly
repeated doxorubicin doses, the amounts per testis of TAG and
A-DAG were reduced to 20% and 50% of their initial levels,
respectively. Although on a percentage basis, the major acyl groups
of triglycerides continued to be PUFA and VLCPUFA (Fig. 5), after
9 weeks, both these lipids had lost most of their original 22:5n-6
and longer pentaenes, their profile resembling the picture shown
for glycerophospholipids in Fig. 4.
In the testis of doxorubicin-treated animals, CE was the only
lipid class to undergo an early, marked, and sustained trend of
increase in both amount and concentration. Thus, 9 weeks after
starting the doxorubicin treatment, CE had become one of the
most important lipid classes of rat testis (Fig. 5). A dual effect was
noted in the amounts of PUFA and VLCPUFA of testicular CE: both
tended to build up after 3 to 4 weeks, whereas after 9 weeks, the
fatty acids mostly responsible for CE accumulation ceased to be
these, being replaced mostly by shorter PUFA with less double
bonds (notably 20:4n-6, but also 22:4n-6, and even 18:2n-6; Fig. 6).
The right of this figure shows that the major PUFA of CE tended to
change in a similar direction to that of the PUFA of the main
phospholipid class, CGP. It is interesting to note that the CGP of
the cells populating the testis 4 weeks after starting doxorubicin
administration had a somewhat higher 22:5n-6/20:4n-6 ratio than
the controls, completely contrary to the situation 5 weeks later.
Figure 4. Decrease in content and change in the composition of testicular
phospholipids in rats that received four doses of doxorubicin (3 mg/kg). White
bars, controls; gray and black bars, doxorubicin treated, after 4 and 9 wks,
respectively. The phospholipid classes depicted are CGP, choline; EGP,
ethanolamine glycerophospholipids, respectively; PI, phosphatidylinositol; PS,
phosphatidylserine; DPG, diphosphatidylglycerol; SM, sphingomyelin. Bottom,
content of n-6 PUFA in the total glycerophospholipids under the same three
conditions, and the percentage of the n -6 PUFA composing that group
(normalized to 100%).
Doxorubicin and Testicular Lipid Fatty Acids
www.aacrjournals.org 6977 Cancer Res 2007; 67: (14). July 15, 2007
Discussion
The results presented here show that treatments with doxoru-
bicin cause an important decrease in testicular weight by reducing
substantially the spermatogenic cell population. An expected but
still striking doxorubicin effect was the notorious decrease in the
amount of the major testicular lipid components, the phospholi-
pids, including glycerophospholipids and sphingomyelin. The
eventual loss of glycerophospholipids was associated with a
significant exhaustion of their main PUFA components, in
particular 22:5n-6, in agreement with this fatty acid being mostly
a germ cell–specific glycerophospholipid fatty acid (13). Coinci-
dentally, a substantial loss of sphingomyelin concurred with the
disappearance from the testis of its typical VLCPUFA.
From the beginning of the doxorubicin treatments, the
VLCPUFA of sphingomyelin and ceramide decreased significantly
after 3 to 4 weeks (Fig. 2) and almost completely disappeared after
9 weeks (Fig. 3). This was consistent with the histologic
observations (Fig. 1) showing partial and total loss, respectively,
of cells of the spermatogenic line at these time points. Because
eventually, only somatic cells survive, the present results support
our interpretation that VLCPUFA-rich species of sphingomyelin
and ceramide are mainly an attribute of the spermatogenic cell line
in the testis. A similarly selective depletion of VLCPUFA-rich
sphingomyelin and ceramide was observed in other models of
germ cell death, including cryptorchidism, ischemia reperfusion,
and X-ray irradiation (16). This idea is also sustained by the fact
that normal spermatozoa of the rat contain sphingomyelin as well
as ceramide with VLCPUFA.1
The single injection of 7.5 mg/kg doxorubicin was useful to
detect an early change affecting the sphingolipids: a significant
increase in ceramide 48 h after this event (Fig. 2). Coincidentally,
48 h after doxorubicin dosing is the reported period necessary to
generate the maximum number of apoptotic cells in the
seminiferous tubules of adult (5) and immature (31) rat testis.
The ceramide-associated fatty acid mostly responsible for this
small peak of ceramide was a saturate, 16:0, the ceramide VLCPUFA
not changing significantly at that moment. Evidence exists in other
non-neural tissues that C-16:0 ceramide represents the ceramide
species increasing in amount in apoptosis (32–35). Although
indirectly, this supports our idea that VLCPUFA-containing species
of testicular ceramide probably are not involved as mediators in
proapoptotic mechanisms. This is one of the few cases in which
in vivo generation of endogenous ceramide is shown in the context of
doxorubicin-induced cell death, and one of a few showing a certain
degree of specificity toward definite molecular species of ceramide.
All lipids of the germ cell–depleted testis differed greatly in
amount and fatty acid composition from their original untreated
counterparts. This included diacylglycerols and ceramides whose
fatty acids showed similar trends of changes as those of
glycerophospholipids and sphingomyelin, respectively, as expected
from their metabolic relation. Thus, after 9 weeks of treatment, (a)
the content of sphingomyelin and ceramide was low and their
major acyl chains were saturated, with a small percentage of
monoenoic and dienoic fatty acids; (b) the amounts of glycer-
ophospholipids and triglycerides had decreased several fold, their
new major PUFA being 20:4n-6 followed by 18:2n-6; (c) the only
lipids that had increased dramatically, accumulating enormous
amounts of 20:4n-6 in place of the original PUFA and VLCPUFA,
were the CEs. This describes the characteristics of the lipids in the
cells that survived doxorubicin effects, among which were Sertoli
and interstitial cells, probably also affected by the drug, directly or
indirectly.
The CE changes observed here as a consequence of doxorubicin
were clearly biphasic: at first, CE, as did triglycerides, tended to
accumulate and to concentrate long-chain PUFA (e.g., 22:5n-6) and
VLCPUFA more than other fatty acids, but in the end, in contrast to
TG, CE continued to accumulate, arachidonic acid predominating
among its acyl groups. We interpret the first part as these neutral
lipids acting as collectors of a fraction of the acyl groups that were
being generated from the membranes of the dying cells.
Concerning CE, the glycerophospholipid-originated free fatty acids
and the free cholesterol located in close contact in apoptotic cell
membranes could become esterified in an energy-dependent way,
Figure 5. Reduction in the amount of lipid fatty acids in rats that received four
doses of doxorubicin (3 mg/kg). White bars, controls; gray and black
bars, doxorubicin-treated rats, after 4 and 9 wks, respectively. GPL, total
glycerophospholipids; DAG, diacylglycerols; TAG, triacylglycerols; A-DAG,
alkyl-diacylglycerols.
1 S. Zanetti et al., 2007, unpublished data.
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thereby generating a lipid innocuous to the cell at the same time as
saving the elements (cholesterol and PUFA) for future use. Because
in the present case, the effects of doxorubicin were irreversible, the
testis did not have the opportunity to use these elements further.
Over time, CE may have become a redundant lipid class,
accumulating merely because these acyl groups had nowhere to
go, considering the impressive testicular involution.
The new, unusually enlarged pool of CE observed here as an end
result of doxorubicin action obviously accumulated in the cells that
survived the effects of the drug. The next question that arises is: in
which cells? Our preferred candidates are Sertoli cells, affected by
the absence of germ cells. In the new setting (no more
spermatogenic cells), they could continue synthesizing fatty acids
that would have no membrane glycerophospholipids to end up in.
Over time, the genes encoding the desaturases and elongases
required to make 22:5n-6 and longer PUFA would be down-
regulated or silenced, the new situation eventually resembling in
many respects that of an immature testis. It would be interesting to
know whether and at which time points of doxorubicin treatment
protein or mRNA levels of the corresponding desaturases or
elongases are potentially down-regulated. The second candidates
to consider could be Leydig cells. As steroidogenic cells, they store
CE in intracellular lipid droplets whose abundance decreases or
increases remarkably after administration of hGC or gonadotro-
phin inhibitors, respectively (36). The first, rate-limiting step in the
synthesis of steroid hormones (removal of cholesterol side chain) in
steroidogenic cells is known to occur in the mitochondria.
Coincidentally, rat testicular mitochondriopathy is another sequel
of repeated doxorubicin treatment (37), the reduced activity of two
steroidogenic enzymes and the lower levels of serum testosterone
also observed (9, 37) being probably secondary to this deleterious
action. Doxorubicin-induced accumulation of CE could thus
reflect in part a reduced use of CE as a source of cholesterol for
testosterone generation.
In conclusion, doxorubicin treatment markedly affected the
content and fatty acid composition of testicular lipids, including
sphingolipids, glycerophospholipids, and neutral lipids. The
importance of these lipid changes is that they occur in vivo .
Early effects on lipids occurred in parallel with the significant
damage the drug produced to the germ cells, whereas in the later
effects, doxorubicin-surviving cells of the testis were the
protagonists. A small peak of ceramide involving 16:0-containing
species may indicate a role for this lipid in the triggering of germ
cell death. The continuously decreasing 22:5n-6–rich glycerophos-
pholipids and VLCPUFA-rich sphingomyelin followed the fate of
the dying germ cells. Among the surviving cells, Sertoli cells could
be responsible for the increased triglycerides and CEs rich in
22:5n-6 and other pentaenes observed after 4 weeks of treatment,
whereas Leydig cells could also be important as contributors of
the accumulation of 20:4n-6–rich CE observed 9 weeks after
doxorubicin treatment. Determining whether this accumulation
results from a physiologic adaptation to the effects of doxorubicin
or reflects just another lipid derangement caused by the drug
remains to be investigated.
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Figure 6. Amounts of PUFA of the n-6 series in testicular CEs and CGPs in control rats (top ) and in rats that received four doses of doxorubicin (3 mg/kg). Middle,
4 wks after and bottom, 9 wks after starting the doxorubicin injections.
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